Save time and get answers to complex questions with AI chat
Motegrity ingredients?Abbvie humira patent cliff navigation success?Is allopurinol expensive?Xiaflex market launch year?When does guselkumab patent expire?
See the DrugPatentWatch profile for kesimpta
Kesimpta (ofatumumab) is a biologic medication. It is a human monoclonal antibody designed to target CD20 on B cells, and it’s marketed as a prescription biologic for multiple sclerosis. [1] Sources: [1] https://www.drugpatentwatch.com/patent/kesimpta
Other Questions About Kesimpta :